|
|
Volumn 8, Issue 7, 2002, Pages 649-650
|
|
Antiretroviral guidelines for resource-limited settings: The WHO's public health approach
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
ANTIVIRUS AGENT;
DIDANOSINE;
EFAVIRENZ;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
INDINAVIR;
LAMIVUDINE;
LOPINAVIR;
NELFINAVIR;
NEVIRAPINE;
NUCLEOSIDE ANALOG;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANEMIA;
CENTRAL NERVOUS SYSTEM DISEASE;
COST BENEFIT ANALYSIS;
DEVELOPING COUNTRY;
DIARRHEA;
DISEASE TRANSMISSION;
DRUG COST;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG SAFETY;
FINANCIAL MANAGEMENT;
GEOGRAPHIC DISTRIBUTION;
HEALTH CARE COST;
HEALTH CARE MANPOWER;
HEALTH CARE NEED;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH ECONOMICS;
HEALTH SERVICE;
HUMAN;
INFECTION PREVENTION;
LABORATORY TEST;
LIVER TOXICITY;
LYMPHOCYTE COUNT;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
SIDE EFFECT;
TERATOGENICITY;
TREATMENT FAILURE;
UNITED NATIONS;
VACCINATION;
VIRUS LOAD;
WORLD HEALTH ORGANIZATION;
ANTIVIRAL AGENTS;
GUIDELINES;
PUBLIC HEALTH;
QUALITY ASSURANCE, HEALTH CARE;
WORLD HEALTH ORGANIZATION;
HUMAN IMMUNODEFICIENCY VIRUS;
|
|
EID: 0036066321
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0702-649 Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
